Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Pathophysiological relevance of the cardiac β2-adrenergic receptor and its potential as a therapeutic target to improve cardiac function.

Pérez-Schindler J, Philp A, Hernandez-Cascales J.

Eur J Pharmacol. 2013 Jan 5;698(1-3):39-47. doi: 10.1016/j.ejphar.2012.11.001. Epub 2012 Nov 23. Review.

PMID:
23183106
2.

The role of cardiac beta1- and beta2-adrenoceptor stimulation in heart failure.

Khamssi M, Brodde OE.

J Cardiovasc Pharmacol. 1990;16 Suppl 5:S133-7. Review.

PMID:
11527117
3.

Testosterone protects rat hearts against ischaemic insults by enhancing the effects of alpha(1)-adrenoceptor stimulation.

Tsang S, Wu S, Liu J, Wong TM.

Br J Pharmacol. 2008 Feb;153(4):693-709. Epub 2007 Dec 24.

4.

Subtype-specific alpha1- and beta-adrenoceptor signaling in the heart.

Xiao RP, Zhu W, Zheng M, Cao C, Zhang Y, Lakatta EG, Han Q.

Trends Pharmacol Sci. 2006 Jun;27(6):330-7. Epub 2006 May 11. Review.

PMID:
16697055
5.
6.
7.

Beta-adrenoceptor signaling pathways mediate cardiac pathological remodeling.

Fu Y, Xiao H, Zhang Y.

Front Biosci (Elite Ed). 2012 Jan 1;4:1625-37. Review.

PMID:
22201979
8.

Distinct beta-adrenergic receptor subtype signaling in the heart and their pathophysiological relevance.

Zheng M, Han QD, Xiao RP.

Sheng Li Xue Bao. 2004 Feb 25;56(1):1-15. Review.

9.

Myocyte adrenoceptor signaling pathways.

Xiang Y, Kobilka BK.

Science. 2003 Jun 6;300(5625):1530-2.

PMID:
12791980
10.

Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts.

Xiao RP, Zhang SJ, Chakir K, Avdonin P, Zhu W, Bond RA, Balke CW, Lakatta EG, Cheng H.

Circulation. 2003 Sep 30;108(13):1633-9. Epub 2003 Sep 15.

11.

Transgenic simulation of human heart failure-like L-type Ca2+-channels: implications for fibrosis and heart rate in mice.

Beetz N, Hein L, Meszaros J, Gilsbach R, Barreto F, Meissner M, Hoppe UC, Schwartz A, Herzig S, Matthes J.

Cardiovasc Res. 2009 Dec 1;84(3):396-406. doi: 10.1093/cvr/cvp251. Epub 2009 Jul 20.

12.
13.

Roles of alpha1A- and alpha1B-adrenoceptors in heart: insights from studies of genetically modified mice.

Woodcock EA.

Clin Exp Pharmacol Physiol. 2007 Sep;34(9):884-8. Review.

PMID:
17645635
14.

Regulation of cardiac contractility by Rab4-modulated beta2-adrenergic receptor recycling.

Odley A, Hahn HS, Lynch RA, Marreez Y, Osinska H, Robbins J, Dorn GW 2nd.

Proc Natl Acad Sci U S A. 2004 May 4;101(18):7082-7. Epub 2004 Apr 22.

15.

Positive inotropic stimulation.

Leone M, Albanèse J, Martin C.

Curr Opin Crit Care. 2002 Oct;8(5):395-403. Review.

PMID:
12357106
16.

Cross-talk of opioid peptide receptor and beta-adrenergic receptor signalling in the heart.

Pepe S, van den Brink OW, Lakatta EG, Xiao RP.

Cardiovasc Res. 2004 Aug 15;63(3):414-22. Review.

PMID:
15276466
17.

The control of cardiomyocyte apoptosis via the beta-adrenergic signaling pathways.

Communal C, Colucci WS.

Arch Mal Coeur Vaiss. 2005 Mar;98(3):236-41. Review.

PMID:
15816327
18.

Cardiac adrenoceptors: physiological and pathophysiological relevance.

Brodde OE, Bruck H, Leineweber K.

J Pharmacol Sci. 2006;100(5):323-37. Epub 2006 Apr 13. Review.

19.
20.

Cardioprotection specific for the G protein Gi2 in chronic adrenergic signaling through beta 2-adrenoceptors.

Foerster K, Groner F, Matthes J, Koch WJ, Birnbaumer L, Herzig S.

Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14475-80. Epub 2003 Nov 11.

Supplemental Content

Support Center